Leyden Labs is a clinical-stage biotech company developing products, specifically nasal sprays containing antibodies, that leverage mucosal immunity to protect humanity from known and future respiratory viruses. Their platform targets commonalities of viral families to help people live freely.
- Category
- Mucosal Immunity
- Stage
- Series B
- Employees
- 91
- HQ
- Leiden, Netherlands
- Founded
- 2020
- Funding
- $257M